Double-Blind, Randomized Trial of Dexmethylphenidate Hydrochloride for the Treatment of Sarcoidosis-Associated Fatigue-Science-Chemical Encyclopedia-lookchem

Double-Blind, Randomized Trial of Dexmethylphenidate Hydrochloride for the Treatment of Sarcoidosis-Associated Fatigue
Add time:08/04/2019 Source:sciencedirect.com

BackgroundFatigue is a common complaint in patients with sarcoidosis. We studied the effectiveness of dexmethylphenidate hydrochloride (d-MPH) in treating sarcoidosis-associated fatigue.

We also recommend Trading Suppliers and Manufacturers of D-THREO-METHYLPHENIDATE HYDROCHLORIDE (cas 19262-68-1). Pls Click Website Link as below: cas 19262-68-1 suppliers

Prev:Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine
Next: Development of enantioselective gas chromatographic quantitation assay for dl-threo-methylphenidate in biological fluids)

Encyclopedia